These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2558336)
41. Point mutational inactivation of the retinoblastoma antioncogene. Horowitz JM; Yandell DW; Park SH; Canning S; Whyte P; Buchkovich K; Harlow E; Weinberg RA; Dryja TP Science; 1989 Feb; 243(4893):937-40. PubMed ID: 2521957 [TBL] [Abstract][Full Text] [Related]
42. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Dyson N; Buchkovich K; Whyte P; Harlow E Cell; 1989 Jul; 58(2):249-55. PubMed ID: 2546678 [TBL] [Abstract][Full Text] [Related]
43. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Dyson N; Howley PM; Münger K; Harlow E Science; 1989 Feb; 243(4893):934-7. PubMed ID: 2537532 [TBL] [Abstract][Full Text] [Related]
44. An SV40 transformation revertant due to a host mutation: isolation and complementation analysis. Silverstein GH; Kohrman DC; Christensen JB; Brockman WW; Imperiale MJ Virology; 1992 Apr; 187(2):723-33. PubMed ID: 1312274 [TBL] [Abstract][Full Text] [Related]
45. Methods to assess inhibition of adipocyte differentiation by SV40 large T antigen. Higgins C; Cherington V Methods Mol Biol; 2001; 165():165-83. PubMed ID: 11217384 [No Abstract] [Full Text] [Related]
46. Transformation and immortalization of Leydig cells from the Sprague-Dawley rat by an early genetic region of simian virus 40 DNA. Nagpal ML; Wang D; Calkins JH; Lin T Cell Tissue Res; 1994 Mar; 275(3):459-65. PubMed ID: 7511058 [TBL] [Abstract][Full Text] [Related]
47. Insufficiency of transformation by simian virus 40, polyomavirus, EJ-ras, or v-myc oncogenes for conversion of ethanolamine-responsive mammary cells to ethanolamine-nonresponsive cells. Kano-Sueoka T; King DM J Virol; 1988 Sep; 62(9):3201-9. PubMed ID: 2841472 [TBL] [Abstract][Full Text] [Related]
48. Selectivity of interferon action in simian virus 40-transformed cells superinfected with simian virus 40. García-Blanco MA; Ghosh PK; Jayaram BM; Ivory S; Lebowitz P; Lengyel P J Virol; 1985 Mar; 53(3):893-8. PubMed ID: 2983099 [TBL] [Abstract][Full Text] [Related]
49. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Carbone M; Pannuti A; Zhang L; Testa JR; Bocchetta M Cancer Res; 2008 Nov; 68(22):9488-96. PubMed ID: 19010924 [TBL] [Abstract][Full Text] [Related]
50. Expression of proto-oncogenes in normal and papovavirus-transformed or -infected rat fibroblasts. Winberry L; Priehs C; Friderici K; Thompson M; Fluck M Virology; 1985 Nov; 147(1):154-68. PubMed ID: 2414921 [TBL] [Abstract][Full Text] [Related]
51. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. Huang S; Wang NP; Tseng BY; Lee WH; Lee EH EMBO J; 1990 Jun; 9(6):1815-22. PubMed ID: 2189724 [TBL] [Abstract][Full Text] [Related]
53. Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses. Felton-Edkins ZA; White RJ J Biol Chem; 2002 Dec; 277(50):48182-91. PubMed ID: 12370195 [TBL] [Abstract][Full Text] [Related]
54. Is there a SV40 middle T antigen? Goldberg YP; Parker MI Med Hypotheses; 1991 Apr; 34(4):334-7. PubMed ID: 1650882 [TBL] [Abstract][Full Text] [Related]
56. Susceptibility of skin fibroblasts from patients with retinoblastoma to transformation by murine sarcoma virus. Miyaki M; Akamatsu N; Ono T; Sasaki MS Cancer Lett; 1983 Mar; 18(2):137-42. PubMed ID: 6299517 [TBL] [Abstract][Full Text] [Related]
58. [Suppressor genes in the malignant transformation and genic deletions in human cancers]. Frebourg T Presse Med; 1989 Oct; 18(31):1519-22. PubMed ID: 2573053 [TBL] [Abstract][Full Text] [Related]
59. Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts. Resnick-Silverman L; Pang Z; Li G; Jha KK; Ozer HL J Virol; 1991 Jun; 65(6):2845-52. PubMed ID: 1851857 [TBL] [Abstract][Full Text] [Related]